text_1: Sanofi's Lantus insulin favored over rival: study.
text_2: A once-daily injection of  Sanofi-Aventis’s insulin drug Lantus controls blood sugar as  effectively as Eli Lilly’s Humalog, which needs to be taken  three times daily, researchers said on Friday.